A new class of biologic agents facing the therapeutic paradigm in psoriasis: anti-IL-23 agents.

about

A new class of biologic agents facing the therapeutic paradigm in psoriasis: anti-IL-23 agents.

Item

http://www.wikidata.org/entity/Q47657450

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

A new class of biologic agents ...... psoriasis: anti-IL-23 agents.

@en

A new class of biologic agents ...... psoriasis: anti-IL-23 agents.

@nl

type

Item

label

A new class of biologic agents ...... psoriasis: anti-IL-23 agents.

@en

A new class of biologic agents ...... psoriasis: anti-IL-23 agents.

@nl

prefLabel

A new class of biologic agents ...... psoriasis: anti-IL-23 agents.

@en

A new class of biologic agents ...... psoriasis: anti-IL-23 agents.

@nl

P1476

A new class of biologic agents ...... n psoriasis: anti-IL-23 agents

@en

P2093

Annalisa Tonini

http://www.w3.org/2001/XMLSchema#string

Salvatore Panduri

http://www.w3.org/2001/XMLSchema#string

P2860

Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12

A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R

Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris

T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines

A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes

A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis

IL-23/IL-17A Dysfunction Phenotypes Inform Possible Clinical Effects from Anti-IL-17A Therapies

Expanding Diversity in Molecular Structures and Functions of the IL-6/IL-12 Heterodimeric Cytokine Family

A unique role for IL-23 in promoting cellular immunity

Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17

P304

135-148

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14712598.2018.1398729

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marco Romanelli

Andrea Chiricozzi

Bruno Gualtieri

P577

2017-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29103330

http://www.w3.org/2001/XMLSchema#string